THE EFFICACY OF PROBIOTICS IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME
Kuang Le
Abstract
Kuang Le
Abstract
[Objective]To evaluate the efficacy of probiotics in the treatment of irritable bowel syndrome.[Methods]Patients in postinfectious irritable bowel syndrome group were medicated with Siliankang 1.5g three times a day for 60 days(group A),the patients were treated with Oryzanol 20mg three times(group B),other patients were controls(group C).The evaluation was performed after 3 months of treatment.[Results]The incidence of irritable bowel syndrome reduced significantly to 2% in group A,while which was 27% in group B and 30% in group C.The difference was significant in three groups.The difference was not significant in patients between group B and group C.[Conclusion]Probiotics is effective in the prevention of irritable bowel syndrome.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
[Objective]To evaluate the efficacy of probiotics in the treatment of irritable bowel syndrome.[Methods]Patients in postinfectious irritable bowel syndrome group were medicated with Siliankang 1.5g three times a day for 60 days(group A),the patients were treated with Oryzanol 20mg three times(group B),other patients were controls(group C).The evaluation was performed after 3 months of treatment.[Results]The incidence of irritable bowel syndrome reduced significantly to 2% in group A,while which was 27% in group B and 30% in group C.The difference was significant in three groups.The difference was not significant in patients between group B and group C.[Conclusion]Probiotics is effective in the prevention of irritable bowel syndrome.
Key concepts: Irritable bowel syndrome, Medicine, Internal medicine, Gastroenterology, Incidence (geometry), Significant difference, Group B, Group A